Azasite Articles
Inspire Pharma abandons CF drug to focus on eye care business
22 February 2011
InSite's AzaSite cleared in Canada for pink eye
2 April 2009
Inspire/InSite's AzaSite debuts in the USA
20 August 2007
Inspire to sell $75M of stock
30 July 2007
InSite and Inspire in ocular antibiotic deal
26 February 2007
InSite prepares NDA on AzaSite
4 July 2005
InSite wins Azalide eye care EPO patent
20 June 2005
InSite enters AzaSite supply deal
23 May 2005
InSite Vision completes $16.5M placing
21 June 2004
Showing 1-10 of 10 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
